Literature DB >> 28387650

A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.

Jenette Creaney1, Ian M Dick2, Justine S Leon2, Bruce W S Robinson2.   

Abstract

Backgound/Aim: Malignant mesothelioma (MM) is an aggressive and fatal pleural cancer. The cell secretome offers information allowing insight into the pathogenesis of MM while offering the possibility to identify potential therapeutic targets and biomarkers. In the present study the secretome protein profile of MM cell lines was compared to normal mesothelial cells.
MATERIALS AND METHODS: Six MM cell lines were compared against three primary mesothelial cell culture preparations using iTRAQ® mass spectrometry.
RESULTS: MM cell lines more abundantly secreted exosome-associated proteins than mesothelial cells. MM cell secretomes were enriched in proteins that are involved in response to stress, carbon metabolism, biosynthesis of amino acids, antigen processing and presentation and protein processing in the endoplasmic reticulum.
CONCLUSION: The MM cell secretome is enriched in proteins that are likely to enhance its growth and response to stress and help it inhibit an adaptive immune response. These are potential targets for therapeutic and biomarker discovery. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Malignant mesothelioma; iTRAQ; proteomics; secretome

Mesh:

Substances:

Year:  2017        PMID: 28387650      PMCID: PMC5369310          DOI: 10.21873/cgp.20023

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  69 in total

Review 1.  p97/p47-Mediated biogenesis of Golgi and ER.

Authors:  Keiji Uchiyama; Hisao Kondo
Journal:  J Biochem       Date:  2005-02       Impact factor: 3.387

2.  More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS.

Authors:  Annette Michalski; Juergen Cox; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-28       Impact factor: 4.466

3.  Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

Authors:  Laura Devis; Cristian P Moiola; Nuria Masia; Elena Martinez-Garcia; Maria Santacana; Tomita Vasilica Stirbat; Françoise Brochard-Wyart; Ángel García; Francesc Alameda; Silvia Cabrera; Jose Palacios; Gema Moreno-Bueno; Miguel Abal; William Thomas; Sylvie Dufour; Xavier Matias-Guiu; Anna Santamaria; Jaume Reventos; Antonio Gil-Moreno; Eva Colas
Journal:  J Pathol       Date:  2017-01-23       Impact factor: 7.996

Review 4.  An overview of cyclophilins in human cancers.

Authors:  J Lee; S S Kim
Journal:  J Int Med Res       Date:  2010 Sep-Oct       Impact factor: 1.671

Review 5.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 6.  P97/CDC-48: proteostasis control in tumor cell biology.

Authors:  Delphine Fessart; Esther Marza; Saïd Taouji; Frédéric Delom; Eric Chevet
Journal:  Cancer Lett       Date:  2013-05-29       Impact factor: 8.679

Review 7.  Calreticulin in the immune system: ins and outs.

Authors:  Malini Raghavan; Sanjeeva J Wijeyesakere; Larry Robert Peters; Natasha Del Cid
Journal:  Trends Immunol       Date:  2012-09-07       Impact factor: 16.687

Review 8.  Control of senescence by CXCR2 and its ligands.

Authors:  Juan C Acosta; Ana O'Loghlen; Ana Banito; Selina Raguz; Jesús Gil
Journal:  Cell Cycle       Date:  2008-10-13       Impact factor: 4.534

9.  Prognostic relevance of LGALS3BP in human colorectal carcinoma.

Authors:  Enza Piccolo; Nicola Tinari; Domenica D'Addario; Cosmo Rossi; Valentina Iacobelli; Rossana La Sorda; Rossano Lattanzio; Maurizia D'Egidio; Annalisa Di Risio; Mauro Piantelli; Pier Giorgio Natali; Stefano Iacobelli
Journal:  J Transl Med       Date:  2015-07-30       Impact factor: 5.531

10.  Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.

Authors:  Michela Capello; Sammy Ferri-Borgogno; Chiara Riganti; Michelle Samuel Chattaragada; Moitza Principe; Cecilia Roux; Weidong Zhou; Emanuel F Petricoin; Paola Cappello; Francesco Novelli
Journal:  Oncotarget       Date:  2016-02-02
View more
  13 in total

1.  Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.

Authors:  Serena Lacerenza; Federica Ciregia; Laura Giusti; Alessandra Bonotti; Viviana Greco; Gino Giannaccini; Vanessa D'Antongiovanni; Poupak Fallahi; Luisa Pieroni; Alfonso Cristaudo; Antonio Lucacchini; Maria Rosa Mazzoni; Rudy Foddis
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

Review 2.  Progress in the Management of Malignant Pleural Mesothelioma in 2017.

Authors:  Amanda J McCambridge; Andrea Napolitano; Aaron S Mansfield; Dean A Fennell; Yoshitaka Sekido; Anna K Nowak; Thanyanan Reungwetwattana; Weimin Mao; Harvey I Pass; Michele Carbone; Haining Yang; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2018-03-08       Impact factor: 15.609

3.  Mouse serum exosomal proteomic signature in response to asbestos exposure.

Authors:  Phillip Munson; Ying-Wai Lam; Maximilian MacPherson; Stacie Beuschel; Arti Shukla
Journal:  J Cell Biochem       Date:  2018-04-16       Impact factor: 4.429

4.  Quantitative Proteomic Analysis of Small and Large Extracellular Vesicles (EVs) Reveals Enrichment of Adhesion Proteins in Small EVs.

Authors:  Lizandra Jimenez; Hui Yu; Andrew J McKenzie; Jeffrey L Franklin; James G Patton; Qi Liu; Alissa M Weaver
Journal:  J Proteome Res       Date:  2019-01-23       Impact factor: 4.466

5.  Proteomic Analysis of Human Dermal Fibroblast Conditioned Medium (DFCM).

Authors:  Manira Maarof; Yogeswaran Lokanathan; Hj Idrus Ruszymah; Aminuddin Saim; Shiplu Roy Chowdhury
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

6.  Integrative Molecular Characterization of Malignant Pleural Mesothelioma.

Authors:  Julija Hmeljak; Francisco Sanchez-Vega; Katherine A Hoadley; Juliann Shih; Chip Stewart; David Heiman; Patrick Tarpey; Ludmila Danilova; Esther Drill; Ewan A Gibb; Reanne Bowlby; Rupa Kanchi; Hatice U Osmanbeyoglu; Yoshitaka Sekido; Jumpei Takeshita; Yulia Newton; Kiley Graim; Manaswi Gupta; Carl M Gay; Lixia Diao; David L Gibbs; Vesteinn Thorsson; Lisa Iype; Havish Kantheti; David T Severson; Gloria Ravegnini; Patrice Desmeules; Achim A Jungbluth; William D Travis; Sanja Dacic; Lucian R Chirieac; Françoise Galateau-Sallé; Junya Fujimoto; Aliya N Husain; Henrique C Silveira; Valerie W Rusch; Robert C Rintoul; Harvey Pass; Hedy Kindler; Marjorie G Zauderer; David J Kwiatkowski; Raphael Bueno; Anne S Tsao; Jenette Creaney; Tara Lichtenberg; Kristen Leraas; Jay Bowen; Ina Felau; Jean Claude Zenklusen; Rehan Akbani; Andrew D Cherniack; Lauren A Byers; Michael S Noble; Jonathan A Fletcher; A Gordon Robertson; Ronglai Shen; Hiroyuki Aburatani; Bruce W Robinson; Peter Campbell; Marc Ladanyi
Journal:  Cancer Discov       Date:  2018-10-15       Impact factor: 39.397

7.  Suppression of OSCC malignancy by oral glands derived-PIP identified by iTRAQ combined with 2D LC-MS/MS.

Authors:  Qibo Wang; Yuan Zhi; Wenhao Ren; Shaoming Li; Zhichao Dou; Xiaoming Xing; Xinyu Quan; Yuting Wang; Chunmiao Jiang; Xiao Liang; Ling Gao; Keqian Zhi
Journal:  J Cell Physiol       Date:  2019-01-28       Impact factor: 6.384

Review 8.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

9.  Proteome sequencing and analysis of Ophiocordyceps sinensis at different culture periods.

Authors:  Bo Zhang; Bo Li; Xiao-Hui Men; Zhe-Wen Xu; Hui Wu; Xiang-Tian Qin; Feng Xu; Yi Teng; Shui-Jin Yuan; Li-Qun Jin; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  BMC Genomics       Date:  2020-12-11       Impact factor: 3.969

10.  S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma.

Authors:  Joëlle S Nader; Jordan Guillon; Coralie Petit; Alice Boissard; Florence Franconi; Stéphanie Blandin; Sylvia Lambot; Marc Grégoire; Véronique Verrièle; Béatrice Nawrocki-Raby; Philippe Birembaut; Olivier Coqueret; Catherine Guette; Daniel L Pouliquen
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.